医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
N-([1,1-联苯]-4-基)-n-(4-溴苯基)-9,9-二甲基-9h-芴-2-胺 | N-([1,1'-biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine | 1246562-40-2 | C33H26BrN |
|
N-(ALPHA,ALPHA,ALPHA-三氟对甲苯)哌嗪 | 1-[4-(trifluoromethyl)phenyl]piperazine | 30459-17-7 | C11H13F3N2 |
|
N-(9-((2R,3R,4R,5R)-5-((双(4-甲氧基苯基)(苯基)甲氧基)甲基)-3-氟-4-羟基四氢呋喃-2-基)-9H-嘌呤-6-基)苯甲酰胺 | N-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide | 136834-21-4 | C38H34FN5O6 |
|
N-(9-(((2R,3R,4R,5R)-4-)羟基-5-(羟甲基)-3-(2-甲氧基乙氧基)四氢呋喃-2-基)-6-氧代-6,9-二氢-1H-嘌呤-2-基)异丁酰胺 | N<sup>2</sup>-isobutyryl-2'-O-(2-methoxyethyl)guanosine | 440327-50-4 | C17H25N5O7 |
|
N-(6-甲酰基吡啶-2-基)三甲基乙酰胺 | 2-pivaloylaminopyridine-6-carboxaldehyde | 372948-82-8 | C11H14N2O2 |
|
N-(6-甲酰基-4-氧代-1H-蝶啶-2-基)乙酰胺 | N<sup>2</sup>-acetyl-6-formylpterin | 29769-49-1 | C9H7N5O3 |
|
N-(6-甲基吡啶-2-基)哌啶-4-甲酰胺 | N-(6-methylpyridin-2-yl)piperidine-4-carboxamide | 110105-99-2 | C12H17N3O |
|
N-(6-甲基吡啶-2-基)哌啶-3-甲酰胺 | N-(6-methylpyridin-2-yl)piperidine-3-carboxamide | 883106-74-9 | C12H17N3O |
|
N-(6-溴吡啶-2-基)乙酰胺 | N-(6-bromo-pyridin-2-yl)acetamide | 25218-99-9 | C7H7BrN2O |
|
N-(6-溴吡啶-2-基)乙胺 | 6-Bromo-2-ethylaminopyridine, HCl | 724770-74-5 | C7H10BrClN2 |
|
N-(6-氯吡啶-2-基)-2,2-二甲基丙酰胺 | N-(6-chloropyridin-2-yl)-2,2-dimethylpropanamide | 86847-84-9 | C10H13ClN2O |
|
N-(6-氯-5-甲基吡啶-2-基)-1-(2,2-二氟苯并[d][1,3]二氧杂环戊烯-5-基)环丙烷-1-羧酰胺 | N-(6-chloro-5-methylpyridin-2-yl)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamide | 936727-68-3 | C17H13ClF2N2O3 |
|
N-(6-氯-3-硝基吡啶-2-基)乙酰胺 | 2-acetamido-6-chloro-3-nitropyridine | 139086-97-8 | C7H6ClN3O3 |
|
N-(6-氯-3-哒嗪基)戊酰胺 | N-(6-chloropyridazin-3-yl)pentanamide | 868948-13-4 | C9H12ClN3O |
|
N-(6-氯-3-哒嗪基)己酰胺 | N-(6-chloropyridazin-3-yl)hexanamide | 868948-14-5 | C10H14ClN3O |
|
N-(6-氯-3-哒嗪基)乙酰胺 | N-(6-chloro-3-pyridazinyl)acetamide | 14959-31-0 | C6H6ClN3O |
|
N-(6-氯-3-哒嗪基)丁酰胺 | N-(6-chloropyridazin-3-yl)butanamide | 868948-12-3 | C8H10ClN3O |
|
N-(6-[生物素胺]己基)-3-(2-吡啶二硫)丙酰胺 | biotin-HPDP | 129179-83-5 | C24H37N5O3S3 |
|
N-(6,7-二氢-6-氧代-1H-嘌呤-2-基)-2-甲基丙酰胺 | 2-N-isobutyrylguanine | 21047-89-2 | C9H11N5O2 |
|
N-(5-硝基-2-吡啶基)-1,2-乙二胺 | 2-(2-aminoethylamino)-5-nitropyridine | 29602-39-9 | C7H10N4O2 |
|
N-(5-甲基吡啶-2-基)哌啶-4-甲酰胺 | N-(5-methylpyridin-2-yl)piperidine-4-carboxamide | 110105-97-0 | C12H17N3O |
|
N-(5-甲基吡啶-2-基)哌啶-3-甲酰胺 | N-(5-methylpyridin-2-yl)piperidine-3-carboxamide | 883106-75-0 | C12H17N3O |
|
N-(5-甲基-1,2-恶唑-3-基)苯甲酰胺 | 3-benzoylamino-5-methylisoxazole | 13053-85-5 | C11H10N2O2 |
|
N-(5-溴-8-喹啉基)乙酰胺 | N-(5-bromoquinolin-8-yl)acetamide | 99851-80-6 | C11H9BrN2O |
|
N-(5-溴-3-甲基吡啶-2-基)-n-甲基苯甲酰胺 | N-(5-bromo-3-methylpyridin-2-yl)-N-methylbenzamide | 446299-80-5 | C14H13BrN2O |
|
N-(5-溴-2-吡啶基)-2-氯乙酰胺 | 2-chloro-N-(2-(5-bromo)pyridinyl)acetamide | 141454-61-7 | C7H6BrClN2O |
|
N-(5-氯苯并[d][1,3]二氧代l-4-基)-7-氟-5-((四氢-2H-吡喃-4-基)氧基)喹唑啉-4-胺 | 7-fluoro-N-(5-chloro-1,3-benzodioxol-4-yl)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine | 379230-38-3 | C20H17ClFN3O4 |
|
N-(5-氯-2-吡啶基)-2-[(4-氰基苯甲酰基)氨基]-5-甲氧基苯甲酰胺盐酸盐 | N-(5-chloro-2-pyridinyl)-2-((4-cyanobenzoyl)amino)-5-methoxybenzamide hydrochloride | 936539-81-0 | C21H15ClN4O3*ClH |
|
N-(5-氯-2-吡啶基)-2-[(4-氰基苯甲酰基)氨基]-5-甲氧基苯甲酰胺 | N-(5-chloropyridin-2-yl)-2-(4-cyanobenzamido)-5-methoxybenzamide | 330942-01-3 | C21H15ClN4O3 |
|
N-(5-氯-2-吡啶)-5-甲氧基-2-氨基苯甲酰胺 | 2-amino-N-(5-chloropyridin-2-yl)-5-methoxybenzamide | 280773-17-3 | C13H12ClN3O2 |
|
N-(5-氨基-2-甲基苯基)-4-(3-吡啶基)-2-氨基嘧啶 | 6-methyl-1-N-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine | 152460-10-1 | C16H15N5 |
|
N-(5-氟-4-甲基吡啶-2-基)乙酰胺 | N1-(5-fluoro-4-methyl-pyridin-2-yl)acetamide | 475060-21-0 | C8H9FN2O |
|
N-(5-(4,5-二氢-(1H)-吲哚-2-基)-2-羟基-5,6,7,8-四氢萘-1-基)甲烷磺酰胺氢溴酸 | A 61603 | 107756-30-9 | BrH*C14H19N3O3S |
|
N-(5,5,8,8-四甲基-5,6,7,8-四氢-2-萘)乙酰胺 (他米巴罗汀) | N-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-acetamide | 139162-43-9 | C16H23NO |
|
N-(4-羟甲基吡啶-2-基)-2,2-二甲基丙酰胺 | N-(4-Hydroxymethyl-pyridin-2-yl)-2,2-dimethyl-propionamide | 551950-45-9 | C11H16N2O2 |
|
N-(4-羟基戊烷酰基)-N-{[2'-(2H-四唑-5-基)-4-联苯基]甲基}-L-缬氨酸 | 4-Hydroxyvalsartan | 188259-69-0 | C24H29N5O4 |
|
N-(4-硝基苯基)-5-氧代-(2S)-2-吡咯烷甲酰胺 | (2S)-5-oxo-2-(4-nitroanilinocarbonyl)pyrrolidine | 66642-35-1 | C11H11N3O4 |
|
N-(4-甲氧基苄基)-n-甲氧基甲基-n-三甲基甲硅烷基甲胺 | 4-methoxy-N-(methoxymethyl)-N-[(trimethylsilyl)methyl]-benzenemethanamine | 433289-59-9 | C14H25NO2Si |
|
N-(4-甲基吡啶-2-基)硝酰胺 | 4-methyl-2-nitraminopyridine | 33245-30-6 | C6H7N3O2 |
|
N-(4-甲基吡啶-2-基)哌啶-4-甲酰胺 | N-(4-methylpyridin-2-yl)piperidine-4-carboxamide | 865078-92-8 | C12H17N3O |
|
N-(4-烯丁基)邻苯二甲酰亚胺 | 1-phthalimido-3-butene | 52898-32-5 | C12H11NO2 |
|
N-(4-溴苯基)吡啶-2-甲酰胺 | N-(4-bromophenyl)picolinamide | 14547-73-0 | C12H9BrN2O |
|
N-(4-溴苯基)-N-苯基-1-萘胺 | N-(4-bromophenyl)-N-phenyl-1-naphthylamine | 138310-84-6 | C22H16BrN |
|
N-(4-溴苯基)-N,N-双(1,1-联苯-4-基)胺 | N-([1,1'-biphenyl]-4-yl)-N-(4-bromophenyl)-[1,1'-biphenyl]-4-amine | 499128-71-1 | C30H22BrN |
|
N-(4-溴苯基)-3-苯基丙酰氨 | N-(4-bromophenyl)-3-phenylpropanamide | 316146-27-7 | C15H14BrNO |
|
N-(4-溴丁基)邻苯二甲酰亚胺 | 2-(4-bromobutyl)isoindoline-1,3-dione | 5394-18-3 | C12H12BrNO2 |
|
N-(4-溴-2-甲基苯基)氨基甲酸叔丁酯 | (4-bromo-2-methylphenyl)carbamic acid tert-butyl ester | 306937-14-4 | C12H16BrNO2 |
|
N-(4-氯苯甲酰基)-酪胺 | 4-chloro-N-(4-hydroxyphenethyl)benzamide | 41859-57-8 | C15H14ClNO2 |
|
N-(4-氯苯基)-N'-[4-氯-3-(三氟甲基)苯基]脲 | cloflucarban | 369-77-7 | C14H9Cl2F3N2O |
|
N-(4-氯-3-氰基-7-乙氧基喹啉-6-基)乙酰胺 | N-(4-chloro-3-cyano-7-ethoxyquinolin-6-yl)acetamide | 848133-76-6 | C14H12ClN3O2 |
|